Affiliation:
1. Department of Radiology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572013, China
2. Department of Neurology, First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
Abstract
Background:
Quantitative susceptibility mapping (QSM) technique had been used to
measure the magnetic susceptibility of brain tissue in clinical practice. However, QSM presented
echo-time (TE) dependence, and an appropriate number of echo-times (nTEs) for QSM became
more important to obtain the reliable susceptibility value.
Objective:
The aim of the study was to explore the optimal nTEs for quantitative susceptibility
mapping (QSM) measurements of basal ganglia nuclei in the healthy brain.
Methods:
3D multi-echo enhanced gradient recalled echo T2 star weighted angiography (ESWAN)
sequence was acquired on a 3.0T MR scanner for QSM analysis. Regions of interests
(ROIs) were drawn along the margin of the head of the caudate nucleus (HCN), putamen (Pu) and
globus pallidus (GP). The mean susceptibility value and standard deviation of the ROIs were derived
from the pixels within each region.
Results:
CV analysis demonstrated that TE6, TE8 and TE14 ESWAN sequences presented consistent
lower CV value (< 1) for QSM measure of HCN, Pu and GP. ANOVA identified that susceptibility
value showed no significant difference between TE6 and TE8 in HCN, Pu and GP (P <
0.05). ICC analysis demonstrated that the susceptibility value of TE6-TE8 had the highest ICC
value as compared with TE6-TE14 and TE8-TE14 in HCN, Pu and GP. Combined with the timeefficiency
of MRI scanning, TE6 sequence could not only provide the reliable QSM measurement
but also short imaging time.
Conclusions:
The current study identified that the optimal nTEs of ESWAN were 6 TEs (2.9ms ~
80.9ms) for QSM measurement of basal ganglia nuclei in the healthy brain.
Publisher
Bentham Science Publishers Ltd.
Subject
Radiology, Nuclear Medicine and imaging
Reference26 articles.
1. Brass S.D.; Chen N.K.; Mulkern R.V.; Bakshi R.; Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 2006,17(1),31-40
2. Jack C.R.; Marjanska M.; Wengenack T.M.; Magnetic resonance imaging of Alzheimer’s pa-thology in the brains of living transgenic mice: A new tool in Alzheimer’s disease research. Neuroscientist 2007,13(1),38-48
3. Bartzokis G.; Tishler T.A.; MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer’s and Huntingon’s disease. Cell Mol Biol 2000,46(4),821-833
4. Chen J.C.; Hardy P.A.; Kucharczyk W.; MR of human postmortem brain tissue: Correla-tive study between T2 and assays of iron and ferritin in Park-inson and Huntington disease. AJNR Am J Neuroradiol 1993,14(2),275-281
5. Bagga D.; Modi S.; Poonia M.; T2 relaxation time alterations underlying neurocognitive deficits in alcohol-use disorders (AUD) in an Indian popula-tion: A combined conventional ROI and voxel-based re-laxometry analysis. Alcohol 2015,49(7),639-646
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献